Kenalog and Iodine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Iodine (iodine). Common drug interactions include diarrhoea among females and hypertransaminasaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Iodine. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Iodine?

Iodine has active ingredients of iodine. It is often used in hypothyroidism. eHealthMe is studying from 3,807 Iodine users. Check the latest studies of Iodine.



On Jul, 10, 2026

17 people who take Kenalog and Iodine together, and have interactions are studied.

Kenalog and Iodine drug interactions.

What are the common drug interactions of Kenalog and Iodine, by gender? *:

female:

  1. Diarrhoea
  2. Oropharyngeal pain
  3. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  4. Erythema (redness of the skin)
  5. Accident at home
  6. Fatigue (feeling of tiredness)
  7. Foot fracture
  8. Herpes zoster
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

  1. Hypertransaminasaemia
  2. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  3. Hepatotoxicity (chemical-driven liver damage)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Infection
  7. Nerve injury
  8. Skin hypopigmentation (loss of skin colour)
  9. White blood cell count increased

What are the common drug interactions of Kenalog and Iodine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Knee arthroplasty
  2. Mobility decreased (ability to move is reduced)
  3. Morton's neuralgia (severe pain on the ball of the foot and at the base of toe)
  4. Plantar fasciitis (painful inflammatory process of the plantar fascia)
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Tarsal tunnel syndrome (a condition that is caused by compression of the tibial nerve or its associated branches as the nerve)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Infection

60+:

  1. Oropharyngeal pain
  2. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  3. Immunoglobulins decreased
  4. Psychotic disorder
  5. Renal failure (kidney dysfunction)
  6. Abdominal distension
  7. Erythema (redness of the skin)
  8. Fall
  9. Hypertransaminasaemia
  10. Limb injury

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 5 people, 29.41%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 29.41%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 29.41%
  4. Primary Immunodeficiency Syndrome: 5 people, 29.41%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 11.76%
  6. Headache (pain in head): 1 person, 5.88%
  7. Asthma: 1 person, 5.88%
  8. Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 5.88%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.88%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Iodine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kenalog and Iodine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Iodine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kenalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Iodine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and iodine (the active ingredients of Kenalog and Iodine, respectively), and Kenalog and Iodine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: